Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

Purpose: To evaluate the overall survival of patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC; metastatic tumor <4 cm, ≤2 metastatic tumors total) receiving neoadjuvant therapy, metastasectomy and/or ablation, and primary tumor resection. Methods: We performed a case–contr...

Full description

Bibliographic Details
Main Authors: Pujan Kandel, Michael B. Wallace, John Stauffer, Candice Bolan, Massimo Raimondo, Timothy A. Woodward, Victoria Gomez, Ashton W. Ritter, Horacio Asbun, Kabir Mody
Format: Article
Language:English
Published: Mary Ann Liebert 2018-11-01
Series:Journal of Pancreatic Cancer
Subjects:
ablation
metastasectomy
overall survival
pancreaticoduodenectomy
pancreatic cancer
Online Access:https://www.liebertpub.com/doi/full/10.1089/PANCAN.2018.0011

Internet

https://www.liebertpub.com/doi/full/10.1089/PANCAN.2018.0011

Similar Items